Soros Fund Management - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$9,135,000
+6.3%
197,179
-62.5%
0.21%
+52.9%
Q1 2018$8,592,000526,5000.14%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders